Control of Sinus Node Tachycardia as an Additional Therapy in Patients With Decompensated Heart Failure (CONSTATHE)
Heart Rate Control as an Additional Therapeutic Strategy in Patients With Decompensated Heart Failure: a Prospective, Randomized, Double-blinded, Placebo-controlled Study.
Sponsor: Fundação de Amparo à Pesquisa do Estado de São Paulo
Listed as NCT02236247, this PHASE1/PHASE2 trial focuses on Decompensated Heart Failure and remains ongoing. Sponsored by Fundação de Amparo à Pesquisa do Estado de São Paulo, it has been updated 7 times since 2013, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Unknown PHASE1/PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Unknown PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE1/PHASE2
Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE1_PHASE2
-
Jan 2019 — Jan 2021 [monthly]
Unknown Status PHASE1_PHASE2
Status: Recruiting → Unknown Status
▶ Show 2 earlier versions
-
Jun 2018 — Jan 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE1_PHASE2
First recorded
May 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- University of Sao Paulo
For direct contact, visit the study record on ClinicalTrials.gov .